Today we're asking Nathalie Moll, Director General of EFPIA:

"How can we future-proof medicines regulation in the post-COVID world?".

Europe’s regulatory system is designed to ensure that new treatments for patients are safe and effective. It has helped to extend and improve the lives of millions of people across Europe and beyond. But to keep pace with developments in science and technology and to remain competitive in the face of fierce global competition, Europe’s regulatory framework has to evolve.